How do in vitro digestion and cell metabolism affect the biological activity and phenolic profile of grape juice and wine
- 5 April 2024
- journal article
- research article
- Published by Elsevier in Food Chemistry
- Vol. 449, 139228
Abstract
No abstract availableKeywords
Funding Information
- Universität Regensburg
- Deutscher Akademischer Austauschdienst
- Republic of Serbia Ministry of Education Science and Technological Development (451-03-47/2023-01/200125, 451-03-47/2023-01/200114)
This publication has 58 references indexed in Scilit:
- Bioaccessibility of phenolic compounds from Brazilian grape juices using a digestion model with intestinal barrier passageFood Bioscience, 2023
- Comparison study between popular brands of coffee, tea and red wine regarding polyphenols content and antioxidant activityFood Chemistry Advances, 2022
- Phenolic composition, antioxidant and antiacetylcholinesterase activities of Opuntia ficus‐indica peel and flower teas after in vitro gastrointestinal digestionJournal of the Science of Food and Agriculture, 2022
- Gains from no real PAINS: Where ‘Fair Trial Strategy’ stands in the development of multi-target ligandsActa Pharmaceutica Sinica B, 2021
- Effects of grape juice consumption on oxidative stress and inflammation in male volleyball players: A randomized, double-blind, placebo-controlled clinical trialComplementary Therapies in Medicine, 2020
- Digestive fate of polyphenols: updated view of the influence of chemical structure and the presence of cell wall materialCurrent Opinion in Food Science, 2020
- First-Pass Metabolism via UDP-Glucuronosyltransferase: a Barrier to Oral Bioavailability of PhenolicsJournal of Pharmaceutical Sciences, 2011
- Absorption of anthocyanins through intestinal epithelial cells – Putative involvement of GLUT2Molecular Nutrition & Food Research, 2009
- Phenolic content and antioxidant activities of white and purple juices manufactured with organically- or conventionally-produced grapesFood and Chemical Toxicology, 2007
- Wine, alcohol, platelets, and the French paradox for coronary heart diseaseThe Lancet, 1992